| Screening and diagnosis of atrial fibrillation using wearable devices |
Yoon Jung Park1, and Myung Hwan Bae2
|
1Division of Cardiology, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea
2Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea |
Corresponding Author:
Myung Hwan Bae , Tel: +82-53-200-5505, Fax: +82-53-426-2046, Email: bmh0325@knu.ac.kr
|
|
Received: November 27, 2023; Revised: December 28, 2023; Accepted: January 6, 2024. |
|
|
Share : 
|
| Abstract |
|
In recent years, the development and use of various devices for the screening of atrial fibrillation (AF) have significantly increased. Such devices include 12-lead electrocardiogram (ECG), photoplethysmography systems, and single-lead ECG and ECG patches. This review outlines several studies that have focused on the feasibility and efficacy of such devices for AF screening, and summarizes the risks and benefits involved in the initiation of anticoagulant therapy after early detection of AF. We also describe several ongoing trials on unresolved issues associated with AF screening. Overall, this review provides a comprehensive summary of the current state of AF screening and its implications for patient care. |
| Keywords:
Atrial fibrillation ; Wearable devices ; Anticoagulants ; Stroke ; Risk assessment |
|
PDF Links
Full text via DOI
Download Citation
